Story thread · 2 reports / 2 sources
Annexon adds month 24 endpoint to phase 3 dry AMD trial
investing.com · 10h · first report
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.
Story thread · 2 reports / 2 sources
investing.com · 10h · first report
Sign in to join the conversation.
No comments yet — start the thread.